ICICI Prudential Mutual Fund decreased its stake in Amrutanjan Health Care Limited from 2.11% to 2.01%, selling 29,812 shares. The value of the shares sold is approximately ₹1.51 crore, based on a share price of ₹509.00.
A heritage pharmaceutical manufacturer specializing in over-the-counter products across pain management, women's hygiene, and packaged beverages, Amrutanjan Health Care has operated since 1893. The company produces ayurvedic balms and wellness solutions, leveraging traditional formulations combined with modern manufacturing practices. Currently managed by third-generation promoters, it maintains a significant presence in India's consumer health sector while focusing on accessible wellness solutions for Indian households and retail markets.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.